Inucard CH Trio 12.5 Tablet
Marketer
Inuen Healthcare Pvt Ltd
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Chlorthalidone (12.5mg)
Overview Inucard CH Trio 12.5 Tablet
Combiflex HT 12.5mg tablets combine multiple agents to manage hypertension when monotherapy proves insufficient. This medication lowers elevated blood pressure, thereby mitigating the risk of future strokes and heart attacks. Take Combiflex HT 12.5mg with food, following your doctor's prescribed dosage based on your individual response. Maintain consistent daily timing. Continue treatment as directed by your physician. The diuretic component increases urination; avoid dosing within four hours of bedtime. Consistent use is crucial for optimal efficacy, even if asymptomatic. Discontinuing treatment elevates the risk of cardiovascular events. Common side effects include edema in the lower extremities, cephalalgia, vertigo, fatigue, and altered taste perception. Report persistent, worsening, or bothersome side effects to your doctor. Increase fluid intake to counter potential dehydration symptoms like myalgia, xerostomia, and polydipsia. Inform your physician of pre-existing hepatic or renal issues before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Always disclose all current medications, especially those for hypertension or cardiac conditions. Regular monitoring of blood pressure, renal function, electrolyte levels, and glycemia is essential to ensure therapeutic efficacy.
Primary Ingredients of Inucard CH Trio 12.5 Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Inucard CH Trio 12.5 Tablet
Elevated arterial blood pressure
Major Benefits of Inucard CH Trio 12.5 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Inucard CH Trio 12.5 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Inucard CH Trio 12.5 Tablet:
- Headache
- Dizziness
- Sleepiness
- Edema (swelling)
- Increased uric acid level in blood
- Fatigue
- Increased blood lipid level
- Increased liver enzymes
- Visual disturbance
- Breathlessness
- Muscle cramp
- Gastrointestinal disturbance
- Electrolyte imbalance
- Increased glucose level in blood
- Urticaria
- Postural hypotension (low blood pressure)
- Impotence
How to use Inucard CH Trio 12.5 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Inucard CH Trio 12.5 Tablet. Ingest the tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.
How Inucard CH Trio 12.5 Tablet works:
Inucard CH Trio 12.5mg tablets contain telmisartan, amlodipine, and chlorthalidone, each contributing to blood pressure reduction. Telmisartan, an angiotensin II receptor antagonist, and amlodipine, a calcium channel blocker, act synergistically to dilate blood vessels, thus lowering blood pressure. Chlorthalidone, a diuretic, facilitates fluid and electrolyte excretion, leading to decreased blood volume and further vasodilation over time.
SAFETY ADVICE
AlcoholUNSAFE
Combining Inucard CH Trio 12.5 Tablet with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Inucard CH Trio 12.5 Tablet during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Tri-component Inucard CH 12.5 mg tablets appear safe for breastfeeding mothers. Available human data indicates minimal infant risk associated with this medication.
DrivingUNSAFE
Driving ability may be impaired by Inucard CH Trio 12.5 Tablet side effects. These side effects can include dizziness, headaches, nausea, or fatigue, potentially impacting concentration and safe driving.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Inucard CH Trio 12.5 mg tablets, potentially requiring dosage modification. Physician consultation is advised; In fact, its use is generally discouraged in such cases.
LiverCAUTION
Patients with liver impairment should use Inucard CH Trio 12.5 mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Inucard CH Trio 12.5 mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Inucard CH Trio 12.5 Tablet :
Should you forget to take a Inucard CH Trio 12.5 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Inucard CH Trio 12.5 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |



